There are only 100 days left for eligible Amazon customers to file a claim in the company's $2.5 billion settlement with the Federal Trade Commission. The window to submit a claim in the settlement ...
One of life’s abiding mysteries—at least to this writer—has been Tesla’s enduring success over recent years despite offering so few choices for customers. With the death of the low-volume and ...
When in 2019 OpenAI finished training a new large language model called GPT-2, the artificial-intelligence lab initially declared it too dangerous to be released. Dario Amodei, then OpenAI’s research ...
Blake has over a decade of experience writing for the web, with a focus on mobile phones, where he covered the smartphone boom of the 2010s and the broader tech scene. When he's not in front of a ...
Following OpenAI’s Sora exit last week, Google today said it’s committed to offering video generation while announcing Veo 3.1 Lite. Veo 3.1 Lite slots under Veo 3.1 Fast, with Veo 3.1 remaining at ...
On Tuesday, Google unveiled Veo 3.1 Lite, its most cost-effective AI video model, and announced plans to cut prices of Veo 3.1 Fast. Shares of Google jumped about 5% on Tuesday. The U.S. tech giant ...
The Federal Trade Commission (FTC) is launching a Healthcare Task Force to better focus its enforcement and advocacy on issues of competition and consumer protection within the industry, it announced ...
Hundreds of thousands of renters across the U.S. are about to receive refund checks after federal regulators accused one of the nation’s largest landlords of inflating the real cost of renting through ...
The Federal Trade Commission (FTC) issued warnings to 97 auto groups around the country, reminding them their advertised prices must be the total price, inclusive of all mandatory fees, that consumers ...
The U.S. Federal Trade Commission is closely monitoring the pharmaceutical industry for potential anticompetitive practices, as some of the blockbuster drugs are nearing the end of their patent ...
FTC focuses on healthcare to protect against high costs Patents for top-selling drugs like Keytruda and Eliquis expiring by decade's end FTC blocks deals to prevent reduced competition and innovation ...
Add Futurism (opens in a new tab) More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results